FINWIRES · TerminalLIVE
FINWIRES

Pharming Gets FDA Approval for Joenja to Treat APDS in Children Aged 4-11

By

Pharming's (PHAR) Joenja tablets have been approved to treat activated phosphoinositide 3-kinase delta syndrome, or APDS, in children 4-11 years who weigh at least 27 kg, the US Food and Drug Administration said Friday.

Joenja was first approved in 2023 for the same indication in patients 12 years and older, the regulator said. APDS is a rare genetic disorder that impairs cells of the immune system.

Shares were about 1.6% higher in afternoon trading.

Price: $10.98, Change: $+0.17, Percent Change: +1.60%

What else is happening in Wire?

Wire

National Beverage Fiscal Q1 Earnings Fall, Revenue Rises

National Beverage (FIZZ) reported fiscal Q1 earnings late Thursday of $0.50 per diluted share, down from $0.60 a year earlier.One analyst polled by FactSet expected $0.59.Revenue in the three months ended Aug. 1 rose to $330.7 million from $330.5 million a year earlier.One analyst projected $342.1 million.National Beverage shares fell 3% in after-hours trading.

$FIZZ
Wire

Zumiez Q2 Loss Widens, Revenue Falls; Sets Q3 Guidance

Zumiez (ZUMZ) reported Thursday Q2 loss of $0.17 per diluted share, compared with loss of $0.06 a year earlier.Two analysts surveyed by FactSet expected a loss of $0.14.Revenue for the quarter ended Aug. 1 was $209.0 million, down from $214.3 million a year ago.Two analysts expected $212.1 million.The company expects Q3 EPS of $0.00 to $0.10 on revenue of $222 million to $226 million. Two analysts expect EPS of $0.59, if comparable, and revenue of $238 million.Shares of the company fell over 15% in after-hours trading.

$ZUMZ
Wire

Box, OpenAI Launch Integration to Access Enterprise Content in ChatGPT

Box (BOX) entered a collaboration with OpenAI to launch an integration that lets users access and work with business content stored in its platform directly from ChatGPT.The integration can help accelerate clinical research, streamline legal workflows, and support financial analysts reviewing company reports, Box said Thursday in a statement.The feature is available starting Thursday for Box customers, with OpenAI rolling out access to users of ChatGPT's paid tiers over the coming days.Price: $34.10, Change: $-0.39, Percent Change: -1.13%

$BOX